Feds charge doctors in multiple states with illegally handing out opioid prescriptions; Vitamin Shoppe to sell more CBD products; Healthcare stocks suffer amid “Medicare for all” speculation.
Sanofi plans $99 monthly insulin package; Indivior accused of fraud; Azar details relationship with Trump.
Walgreens plans to sell CBD products; J&J cleared of liability in New Jersey lawsuit; Health insurer Centene plans to buy WellCare.
Novo submits diabetes pill for ‘priority review’; Top FDA compounding staffer to exit; Roman launches women’s product
The acquisition represents the U.K. health network’s third in the U.S.
Jury awards $29 million in J&J talc case; Mental health disorders linked to social media; The rundown on Haven.
FDA proposes more e-cigarette regulations; Congress invites PBMs to Hill; Novo, AstraZeneca pull ads from Fox News.
What’s waiting on the desk of the next FDA commissioner.
Amazon names its healthcare venture Haven; BMS urges investors to back Celgene deal; Advisory council wants Canadian national drug agency; The latest edition of The MM&M Podcast.
Gottlieb to quit FDA; Five of pharma’s top digital innovators; Matter launches dedicated healthcare shop.
